The unusual activation of AR signaling and its resurgence even after castration is a major hallmark of PCa in most clinical cases and hurdle to overcome it but could be a steppingstone toward taming the challenge with the advent of novel AR‐degraders [23, 24, 25]. The gene discussed is AR; the disease is posterior cortical atrophy.